| pubmed-article:18550267 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18550267 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:18550267 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:18550267 | lifeskim:mentions | umls-concept:C0007134 | lld:lifeskim |
| pubmed-article:18550267 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
| pubmed-article:18550267 | lifeskim:mentions | umls-concept:C0036043 | lld:lifeskim |
| pubmed-article:18550267 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
| pubmed-article:18550267 | lifeskim:mentions | umls-concept:C1334043 | lld:lifeskim |
| pubmed-article:18550267 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
| pubmed-article:18550267 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:18550267 | pubmed:dateCreated | 2009-12-9 | lld:pubmed |
| pubmed-article:18550267 | pubmed:abstractText | In a phase-III trial it was recently shown that an adjuvant renal cell carcinoma (RCC) vaccine (Reniale) reduces the risk of tumour progression following nephrectomy. This clinical trial focused on efficacy and did not investigate end-points relating to mode-of-action of the vaccine. In a murine model we investigated mode-of-action, efficacy, and safety of a homologous RENCA cell-based vaccine. | lld:pubmed |
| pubmed-article:18550267 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18550267 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18550267 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18550267 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18550267 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18550267 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18550267 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18550267 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:18550267 | pubmed:issn | 1873-7560 | lld:pubmed |
| pubmed-article:18550267 | pubmed:author | pubmed-author:JochamDieterD | lld:pubmed |
| pubmed-article:18550267 | pubmed:author | pubmed-author:PauelsHans-Ge... | lld:pubmed |
| pubmed-article:18550267 | pubmed:author | pubmed-author:DrevsJoachimJ | lld:pubmed |
| pubmed-article:18550267 | pubmed:author | pubmed-author:EsserNorbertN | lld:pubmed |
| pubmed-article:18550267 | pubmed:author | pubmed-author:DoehnChristia... | lld:pubmed |
| pubmed-article:18550267 | pubmed:author | pubmed-author:StelljesMatth... | lld:pubmed |
| pubmed-article:18550267 | pubmed:author | pubmed-author:KiessigStepha... | lld:pubmed |
| pubmed-article:18550267 | pubmed:author | pubmed-author:GrossmannArmi... | lld:pubmed |
| pubmed-article:18550267 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18550267 | pubmed:volume | 56 | lld:pubmed |
| pubmed-article:18550267 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18550267 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18550267 | pubmed:pagination | 123-31 | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:meshHeading | pubmed-meshheading:18550267... | lld:pubmed |
| pubmed-article:18550267 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:18550267 | pubmed:articleTitle | Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinoma. | lld:pubmed |
| pubmed-article:18550267 | pubmed:affiliation | Department of Urology, University of Lübeck Medical School, Lübeck, Germany. doehn@medinf.mu-luebeck.de | lld:pubmed |
| pubmed-article:18550267 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18550267 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18550267 | lld:pubmed |
